Dr Reddy's Lab announces strategic deal with Gland Pharma in US market

The portfolio is a mix of filed ANDAs pending approval by the US Food and Drug Administration (USFDA) and ANDAs that will be filed imminently. The portfolio comprised of generic injectables administered in hospitals and clinics in the US.

Created On: Oct 27, 2016 13:02 ISTModified On: Oct 27, 2016 12:33 IST

Pharmaceutical giant Dr Reddy's Laboratories Ltd on 26 October 2016 announced that it entered into a strategic collaboration with Gland Pharma. The companies entered into the deal to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications (ANDAs).

The portfolio is a mix of filed ANDAs pending approval by the US Food and Drug Administration (USFDA) and ANDAs that will be filed imminently. The portfolio comprised of generic injectables administered in hospitals and clinics in the US.

CA eBook

About Dr Reddy's Laboratories

Dr Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad, Telangana.

The company was founded by Anji Reddy, who previously worked in the mentor institute, Indian Drugs and Pharmaceuticals Limited.

Dr Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas.

The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care and biotechnology products.

 

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

एग्जाम की तैयारी के लिए ऐप पर वीकली टेस्ट लें और दूसरों के साथ प्रतिस्पर्धा करें। डाउनलोड करें करेंट अफेयर्स ऐप

AndroidIOS
Comment ()

Post Comment

9 + 4 =
Post

Comments